Advancing the future of CAR T cell detection through innovative flow cytometry solutions that deliver consistency, reproducibility, and reliability across global laboratories.
BlueRay Precision GmbH is dedicated to making global standardization in cell therapy detection both accessible and affordable. We develop high-quality flow cytometry reagents and reference materials that enable consistent, reproducible CAR T cell detection across laboratories and instrument platforms.
By focusing on batch-to-batch consistency, universal workflow compatibility, and validated performance, we help laboratories generate comparable data that supports meaningful scientific and clinical insights.
Operating from Heidelberg, Germany, we combine scientific rigor with practical understanding of laboratory workflows to deliver solutions that address real-world challenges in CAR T cell detection.
100%
Flow Cytometry Focus
RUO
Research Grade
QC
Validated Products
Global
Partnerships
Core principles that guide every decision we make and every product we develop.
Precision in design, manufacturing, and performance validation
Clear documentation and open communication with customers
Consistent performance you can rely on across batches and time
Making standardization accessible through optimized production
A team of scientists and engineers united by a passion for advancing cell therapy detection.
BlueRay Precision was founded by an interdisciplinary team with deep expertise in immunology, flow cytometry, analytical chemistry, and bioprocess development. Our team brings together decades of combined experience in cell therapy research, diagnostic development, and quality control systems.
This diverse background enables us to understand both the scientific fundamentals and the practical realities of laboratory workflows, resulting in products that are not only technically sophisticated but also straightforward to implement in any research environment.
At the heart of Europe's leading life science ecosystem.
We are based in Heidelberg, one of Europe's leading life science hubs. This location provides access to world-class research institutions, clinical centers, and biotechnology expertise.
The region's concentration of cell therapy research and development activities makes it an ideal environment for developing and validating our standardization solutions.
The SCOPE platform is built on a foundation of protected intellectual property and proprietary production know-how. Our IP portfolio safeguards the innovative approaches that enable the unique performance characteristics of our products.
This intellectual property protection ensures long-term product availability and continued development of the SCOPE ecosystem. We are committed to maintaining our IP rights while making our standardization solutions accessible to the cell therapy community.